| RS1804568176 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1804617510 |
HGSNAT
|
Health Risk |
Pathogenic |
Sanfilippo syndrome, Sanfilippo syndrome |
| RS1804688 |
NDUFS8
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS1804692531 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Lethal congenital glycogen storage disease of heart |
| RS1804721948 |
PRKAG2
|
Health Risk |
Pathogenic |
Lethal congenital glycogen storage disease of heart, Lethal congenital glycogen storage disease of heart |
| RS1804723787 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Lethal congenital glycogen storage disease of heart |
| RS1804744616 |
CYP7B1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1804769861 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 73, Retinitis pigmentosa 73 |
| RS1804770574 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804781641 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1804782152 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 73, Retinitis pigmentosa 73 |
| RS1804790650 |
ESCO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Roberts-SC phocomelia syndrome, Juberg-Hayward syndrome |
| RS1804799075 |
FOXP2
|
Health Risk |
Likely pathogenic |
— |
| RS1804799285 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804800490 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1804800800 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1804802088 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804802146 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804802649 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804804514 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1804806714 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804811181 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804814100 |
ESCO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Juberg-Hayward syndrome, Roberts-SC phocomelia syndrome |
| RS1804819972 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1804841321 |
ARFGEF1
|
Health Risk |
Pathogenic |
Delayed speech and language development, Atypical behavior |
| RS1804892169 |
ESCO2
|
Health Risk |
Likely pathogenic |
Roberts-SC phocomelia syndrome, Roberts-SC phocomelia syndrome |
| RS1804893340 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1804922106 |
FOXP2
|
Health Risk |
Pathogenic |
— |
| RS1804990594 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1804991326 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS1804993220 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1804995748 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805006 |
MC1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, cutaneous malignant |
| RS1805007 |
MC1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Skin/hair/eye pigmentation 2, red hair/fair skin |
| RS1805008 |
MC1R;TUBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Increased analgesia from kappa-opioid receptor agonist, female-specific |
| RS1805009 |
MC1R
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
Skin/hair/eye pigmentation 2, red hair/fair skin |
| RS1805031 |
CACNB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS1805032 |
CACNB4
|
Health Risk |
risk factor |
Epilepsy, juvenile myoclonic |
| RS1805069 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1805076 |
PPP2R1B
|
Health Risk |
Pathogenic |
Lung carcinoma, Lung carcinoma |
| RS1805082639 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1805083417 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1805090 |
AGT
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, AGT-related disorder |
| RS1805097 |
IRS2
|
Health Risk |
Benign; risk factor |
IRS2-related disorder, Type 2 diabetes mellitus |
| RS1805101 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS1805124855 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1805128 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity; other; risk factor |
Long QT syndrome 2/5, digenic |
| RS1805137 |
PEX7
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS1805142 |
BEST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitelliform macular dystrophy 2, Retinal dystrophy |
| RS1805142029 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805143 |
BEST1;FTH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitelliform macular dystrophy 2, Retinal dystrophy |
| RS1805143456 |
CHD7
|
Health Risk |
Pathogenic |
Scoliosis, isolated |
| RS1805144 |
BEST1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1805157634 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805159 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS1805160 |
XPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum group A, Xeroderma pigmentosum |
| RS1805177 |
CFTR
|
Health Risk |
Pathogenic |
Bronchiectasis with or without elevated sweat chloride 1, modifier of |
| RS1805186461 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1805188732 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1805190 |
EIF2AK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Wolcott-Rallison dysplasia |
| RS1805253922 |
CYP7B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital bile acid synthesis defect 3, Spastic paraplegia |
| RS1805300035 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1805303504 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS1805310101 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805310365 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805311016 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805318 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1805322 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1805323 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1805323000 |
DDHD2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS1805335711 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805338299 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, Inborn genetic diseases |
| RS1805352418 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1805354 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS1805354051 |
ARFGEF1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1805364 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS1805378 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS1805378816 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1805405695 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
3MC syndrome, CHARGE syndrome |
| RS1805413419 |
CYP7B1
|
Health Risk |
Pathogenic |
— |
| RS1805418179 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1805435464 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1805443015 |
CYP7B1
|
Health Risk |
Pathogenic |
— |
| RS1805486327 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805491311 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1805501026 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805504949 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805505628 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1805506816 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1805513214 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805529214 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805535866 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1805544418 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1805547113 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1805550477 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1805560892 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1805566024 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, Inborn genetic diseases |
| RS1805570234 |
CHD7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1805571443 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1805573066 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |